Report Detail

Pharma & Healthcare Global Colorectal Cancer Therapeutics Market Research Report 2019

  • RnM2728600
  • |
  • 06 February, 2019
  • |
  • Global
  • |
  • 103 Pages
  • |
  • QYResearch
  • |
  • Pharma & Healthcare

Colorectal cancer (CRC), also known as bowel cancer and colon cancer, is the development of cancer from the colon or rectum (parts of the large intestine). A cancer is the abnormal growth of cells that have the ability to invade or spread to other parts of the body. Signs and symptoms may include blood in the stool, a change in bowel movements, weight loss, and feeling tired all the time

The global Colorectal Cancer Therapeutics market is valued at xx million US$ in 2018 is expected to reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025.
This report focuses on Colorectal Cancer Therapeutics volume and value at global level, regional level and company level. From a global perspective, this report represents overall Colorectal Cancer Therapeutics market size by analyzing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, China and Japan.
At company level, this report focuses on the production capacity, ex-factory price, revenue and market share for each manufacturer covered in this report.

The following manufacturers are covered:
Taiho Pharma
Merck KGaA
Amgen
Takeda
Roche
Eli Lilly
Sanofi
Regeneron
Bayer
Onyx
Bristol-Myers Squib
Sumitomo Dainippon Pharma
Array BioPharma
Hutchison MediPharma
Jiangsu Hengrui Medicine
Jiangsu Chia-Tai Tianqing
Suzhou Zelgen Biopharmaceuticals

Segment by Regions
North America
Europe
China
Japan

Segment by Type
Diagnostics
Therapeutics

Segment by Application
Hospitals
Clinic
Research institutions


Table of Contents

    Executive Summary

      1 Colorectal Cancer Therapeutics Market Overview

      • 1.1 Product Overview and Scope of Colorectal Cancer Therapeutics
      • 1.2 Colorectal Cancer Therapeutics Segment by Type
        • 1.2.1 Global Colorectal Cancer Therapeutics Production Growth Rate Comparison by Type (2014-2025)
        • 1.2.2 Diagnostics
        • 1.2.3 Therapeutics
      • 1.3 Colorectal Cancer Therapeutics Segment by Application
        • 1.3.1 Colorectal Cancer Therapeutics Consumption Comparison by Application (2014-2025)
        • 1.3.2 Hospitals
        • 1.3.3 Clinic
        • 1.3.4 Research institutions
      • 1.3 Global Colorectal Cancer Therapeutics Market by Region
        • 1.3.1 Global Colorectal Cancer Therapeutics Market Size Region
        • 1.3.2 North America Status and Prospect (2014-2025)
        • 1.3.3 Europe Status and Prospect (2014-2025)
        • 1.3.4 China Status and Prospect (2014-2025)
        • 1.3.5 Japan Status and Prospect (2014-2025)
        • 1.3.6 Southeast Asia Status and Prospect (2014-2025)
        • 1.3.7 India Status and Prospect (2014-2025)
      • 1.4 Global Colorectal Cancer Therapeutics Market Size
        • 1.4.1 Global Colorectal Cancer Therapeutics Revenue (2014-2025)
        • 1.4.2 Global Colorectal Cancer Therapeutics Production (2014-2025)

      2 Global Colorectal Cancer Therapeutics Market Competition by Manufacturers

      • 2.1 Global Colorectal Cancer Therapeutics Production Market Share by Manufacturers (2014-2019)
      • 2.2 Global Colorectal Cancer Therapeutics Revenue Share by Manufacturers (2014-2019)
      • 2.3 Global Colorectal Cancer Therapeutics Average Price by Manufacturers (2014-2019)
      • 2.4 Manufacturers Colorectal Cancer Therapeutics Production Sites, Area Served, Product Types
      • 2.5 Colorectal Cancer Therapeutics Market Competitive Situation and Trends
        • 2.5.1 Colorectal Cancer Therapeutics Market Concentration Rate
        • 2.5.2 Colorectal Cancer Therapeutics Market Share of Top 3 and Top 5 Manufacturers
        • 2.5.3 Mergers & Acquisitions, Expansion

      3 Global Colorectal Cancer Therapeutics Production Market Share by Regions

      • 3.1 Global Colorectal Cancer Therapeutics Production Market Share by Regions
      • 3.2 Global Colorectal Cancer Therapeutics Revenue Market Share by Regions (2014-2019)
      • 3.3 Global Colorectal Cancer Therapeutics Production, Revenue, Price and Gross Margin (2014-2019)
      • 3.4 North America Colorectal Cancer Therapeutics Production
        • 3.4.1 North America Colorectal Cancer Therapeutics Production Growth Rate (2014-2019)
        • 3.4.2 North America Colorectal Cancer Therapeutics Production, Revenue, Price and Gross Margin (2014-2019)
      • 3.5 Europe Colorectal Cancer Therapeutics Production
        • 3.5.1 Europe Colorectal Cancer Therapeutics Production Growth Rate (2014-2019)
        • 3.5.2 Europe Colorectal Cancer Therapeutics Production, Revenue, Price and Gross Margin (2014-2019)
      • 3.6 China Colorectal Cancer Therapeutics Production (2014-2019)
        • 3.6.1 China Colorectal Cancer Therapeutics Production Growth Rate (2014-2019)
        • 3.6.2 China Colorectal Cancer Therapeutics Production, Revenue, Price and Gross Margin (2014-2019)
      • 3.7 Japan Colorectal Cancer Therapeutics Production (2014-2019)
        • 3.7.1 Japan Colorectal Cancer Therapeutics Production Growth Rate (2014-2019)
        • 3.7.2 Japan Colorectal Cancer Therapeutics Production, Revenue, Price and Gross Margin (2014-2019)

      4 Global Colorectal Cancer Therapeutics Consumption by Regions

      • 4.1 Global Colorectal Cancer Therapeutics Consumption by Regions
      • 4.2 North America Colorectal Cancer Therapeutics Consumption (2014-2019)
      • 4.3 Europe Colorectal Cancer Therapeutics Consumption (2014-2019)
      • 4.4 China Colorectal Cancer Therapeutics Consumption (2014-2019)
      • 4.5 Japan Colorectal Cancer Therapeutics Consumption (2014-2019)

      5 Global Colorectal Cancer Therapeutics Production, Revenue, Price Trend by Type

      • 5.1 Global Colorectal Cancer Therapeutics Production Market Share by Type (2014-2019)
      • 5.2 Global Colorectal Cancer Therapeutics Revenue Market Share by Type (2014-2019)
      • 5.3 Global Colorectal Cancer Therapeutics Price by Type (2014-2019)
      • 5.4 Global Colorectal Cancer Therapeutics Production Growth by Type (2014-2019)

      6 Global Colorectal Cancer Therapeutics Market Analysis by Applications

      • 6.1 Global Colorectal Cancer Therapeutics Consumption Market Share by Application (2014-2019)
      • 6.2 Global Colorectal Cancer Therapeutics Consumption Growth Rate by Application (2014-2019)

      7 Company Profiles and Key Figures in Colorectal Cancer Therapeutics Business

      • 7.1 Taiho Pharma
        • 7.1.1 Taiho Pharma Colorectal Cancer Therapeutics Production Sites and Area Served
        • 7.1.2 Colorectal Cancer Therapeutics Product Introduction, Application and Specification
        • 7.1.3 Taiho Pharma Colorectal Cancer Therapeutics Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.1.4 Main Business and Markets Served
      • 7.2 Merck KGaA
        • 7.2.1 Merck KGaA Colorectal Cancer Therapeutics Production Sites and Area Served
        • 7.2.2 Colorectal Cancer Therapeutics Product Introduction, Application and Specification
        • 7.2.3 Merck KGaA Colorectal Cancer Therapeutics Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.2.4 Main Business and Markets Served
      • 7.3 Amgen
        • 7.3.1 Amgen Colorectal Cancer Therapeutics Production Sites and Area Served
        • 7.3.2 Colorectal Cancer Therapeutics Product Introduction, Application and Specification
        • 7.3.3 Amgen Colorectal Cancer Therapeutics Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.3.4 Main Business and Markets Served
      • 7.4 Takeda
        • 7.4.1 Takeda Colorectal Cancer Therapeutics Production Sites and Area Served
        • 7.4.2 Colorectal Cancer Therapeutics Product Introduction, Application and Specification
        • 7.4.3 Takeda Colorectal Cancer Therapeutics Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.4.4 Main Business and Markets Served
      • 7.5 Roche
        • 7.5.1 Roche Colorectal Cancer Therapeutics Production Sites and Area Served
        • 7.5.2 Colorectal Cancer Therapeutics Product Introduction, Application and Specification
        • 7.5.3 Roche Colorectal Cancer Therapeutics Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.5.4 Main Business and Markets Served
      • 7.6 Eli Lilly
        • 7.6.1 Eli Lilly Colorectal Cancer Therapeutics Production Sites and Area Served
        • 7.6.2 Colorectal Cancer Therapeutics Product Introduction, Application and Specification
        • 7.6.3 Eli Lilly Colorectal Cancer Therapeutics Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.6.4 Main Business and Markets Served
      • 7.7 Sanofi
        • 7.7.1 Sanofi Colorectal Cancer Therapeutics Production Sites and Area Served
        • 7.7.2 Colorectal Cancer Therapeutics Product Introduction, Application and Specification
        • 7.7.3 Sanofi Colorectal Cancer Therapeutics Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.7.4 Main Business and Markets Served
      • 7.8 Regeneron
        • 7.8.1 Regeneron Colorectal Cancer Therapeutics Production Sites and Area Served
        • 7.8.2 Colorectal Cancer Therapeutics Product Introduction, Application and Specification
        • 7.8.3 Regeneron Colorectal Cancer Therapeutics Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.8.4 Main Business and Markets Served
      • 7.9 Bayer
        • 7.9.1 Bayer Colorectal Cancer Therapeutics Production Sites and Area Served
        • 7.9.2 Colorectal Cancer Therapeutics Product Introduction, Application and Specification
        • 7.9.3 Bayer Colorectal Cancer Therapeutics Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.9.4 Main Business and Markets Served
      • 7.10 Onyx
        • 7.10.1 Onyx Colorectal Cancer Therapeutics Production Sites and Area Served
        • 7.10.2 Colorectal Cancer Therapeutics Product Introduction, Application and Specification
        • 7.10.3 Onyx Colorectal Cancer Therapeutics Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.10.4 Main Business and Markets Served
      • 7.11 Bristol-Myers Squib
      • 7.12 Sumitomo Dainippon Pharma
      • 7.13 Array BioPharma
      • 7.14 Hutchison MediPharma
      • 7.15 Jiangsu Hengrui Medicine
      • 7.16 Jiangsu Chia-Tai Tianqing
      • 7.17 Suzhou Zelgen Biopharmaceuticals

      8 Colorectal Cancer Therapeutics Manufacturing Cost Analysis

      • 8.1 Colorectal Cancer Therapeutics Key Raw Materials Analysis
        • 8.1.1 Key Raw Materials
        • 8.1.2 Price Trend of Key Raw Materials
        • 8.1.3 Key Suppliers of Raw Materials
      • 8.2 Proportion of Manufacturing Cost Structure
      • 8.3 Manufacturing Process Analysis of Colorectal Cancer Therapeutics
      • 8.4 Colorectal Cancer Therapeutics Industrial Chain Analysis

      9 Marketing Channel, Distributors and Customers

      • 9.1 Marketing Channel
        • 9.1.1 Direct Marketing
        • 9.1.2 Indirect Marketing
      • 9.2 Colorectal Cancer Therapeutics Distributors List
      • 9.3 Colorectal Cancer Therapeutics Customers

      10 Market Dynamics

      • 10.1 Market Trends
      • 10.2 Opportunities
      • 10.3 Market Drivers
      • 10.4 Challenges
      • 10.5 Influence Factors

      11 Global Colorectal Cancer Therapeutics Market Forecast

      • 11.1 Global Colorectal Cancer Therapeutics Production, Revenue Forecast
        • 11.1.1 Global Colorectal Cancer Therapeutics Production Growth Rate Forecast (2019-2025)
        • 11.1.2 Global Colorectal Cancer Therapeutics Revenue and Growth Rate Forecast (2019-2025)
        • 11.1.3 Global Colorectal Cancer Therapeutics Price and Trend Forecast (2019-2025)
      • 11.2 Global Colorectal Cancer Therapeutics Production Forecast by Regions (2019-2025)
        • 11.2.1 North America Colorectal Cancer Therapeutics Production, Revenue Forecast (2019-2025)
        • 11.2.2 Europe Colorectal Cancer Therapeutics Production, Revenue Forecast (2019-2025)
        • 11.2.3 China Colorectal Cancer Therapeutics Production, Revenue Forecast (2019-2025)
        • 11.2.4 Japan Colorectal Cancer Therapeutics Production, Revenue Forecast (2019-2025)
      • 11.3 Global Colorectal Cancer Therapeutics Consumption Forecast by Regions (2019-2025)
        • 11.3.1 North America Colorectal Cancer Therapeutics Consumption Forecast (2019-2025)
        • 11.3.2 Europe Colorectal Cancer Therapeutics Consumption Forecast (2019-2025)
        • 11.3.3 China Colorectal Cancer Therapeutics Consumption Forecast (2019-2025)
        • 11.3.4 Japan Colorectal Cancer Therapeutics Consumption Forecast (2019-2025)
      • 11.4 Global Colorectal Cancer Therapeutics Production, Revenue and Price Forecast by Type (2019-2025)
      • 11.5 Global Colorectal Cancer Therapeutics Consumption Forecast by Application (2019-2025)

      12 Research Findings and Conclusion

        13 Methodology and Data Source

        • 13.1 Methodology/Research Approach
          • 13.1.1 Research Programs/Design
          • 13.1.2 Market Size Estimation
          • 13.1.3 Market Breakdown and Data Triangulation
        • 13.2 Data Source
          • 13.2.1 Secondary Sources
          • 13.2.2 Primary Sources
        • 13.3 Author List

        Summary:
        Get latest Market Research Reports on Colorectal Cancer Therapeutics. Industry analysis & Market Report on Colorectal Cancer Therapeutics is a syndicated market report, published as Global Colorectal Cancer Therapeutics Market Research Report 2019. It is complete Research Study and Industry Analysis of Colorectal Cancer Therapeutics market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

        Last updated on

        REPORT YOU MIGHT BE INTERESTED

        Purchase this Report

        $2,900.00
        $4,350.00
        $5,800.00
        2,235.90
        3,353.85
        4,471.80
        2,685.40
        4,028.10
        5,370.80
        444,396.00
        666,594.00
        888,792.00
        244,557.00
        366,835.50
        489,114.00
        Credit card Logo

        Related Reports


        Reason to Buy

        Request for Sample of this report